291 participants
A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-08-22
- Start Date:
- 2016-07-11
- Completion:
- 2021-03-15
Conditions
- Relapsed/Refractory Multiple Myeloma
Interventions
- DRUG